1. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1206,
1999,
Page 2-2
&NA;,
Preview
|
PDF (905KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
2. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1206,
1999,
Page 3-3
&NA;,
Preview
|
PDF (786KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
3. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1206,
1999,
Page 4-4
&NA;,
Preview
|
PDF (804KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
4. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1206,
1999,
Page 5-5
&NA;,
Preview
|
PDF (733KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
5. |
Long-term riluzole therapy cost effective in ALS patients |
|
Inpharma Weekly,
Volume &NA;,
Issue 1206,
1999,
Page 6-6
&NA;,
Preview
|
PDF (864KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
6. |
Parecoxibgrinding away at dental pain |
|
Inpharma Weekly,
Volume &NA;,
Issue 1206,
1999,
Page 7-8
Carmen Innes,
Preview
|
PDF (856KB)
|
|
摘要:
Parecoxib has comparable analgesic activity to ketorolac in patients with postoperative dental pain, according to new clinical trial results presented at the 9th World Congress on Pain [Vienna, Austria; August 1999]. IV or IM parecoxib provides pain relief over a wide range of doses and is well tolerated.
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
7. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1206,
1999,
Page 8-8
&NA;,
Preview
|
PDF (830KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
8. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1206,
1999,
Page 9-9
&NA;,
Preview
|
PDF (787KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
9. |
Addition of ancestim improves leukapheresis cell yield |
|
Inpharma Weekly,
Volume &NA;,
Issue 1206,
1999,
Page 10-10
&NA;,
Preview
|
PDF (812KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
10. |
Venlafaxine keeps the blues away |
|
Inpharma Weekly,
Volume &NA;,
Issue 1206,
1999,
Page 11-12
Carmen Innes,
Preview
|
PDF (1602KB)
|
|
摘要:
Wyeth-Ayerst's venlafaxine [‘Effexor’] appears to provide better remission rates in patients with depression compared with selective serotonin reuptake inhibitors (SSRIs). These results, from a meta-analysis of 8 clinical studies, were presented at the 11th World Congress of Psychiatry [Hamburg, Germany; August 1999]. Also presented were trials showing that venlafaxine improves cognition in elderly patients with depression compared with dothiepin, and that extended-release (XR) venlafaxine is effective in preventing relapse in patients with depression.
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|